Trial
NCT05414500
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Alabama at Birmingham
Collaborators
Seagen Inc.; Kyowa Kirin, Inc.
Condition
Cutaneous T Cell Lymphoma
Intervention
Mogamulizumab
Why stopped
IRB audit
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-15